BASELINE 4K SCORE PREDICTS PROGRESSION ON ACTIVE SURVEILLANCE IN PROSTATE CANCER INDEPENDENTLY OF CLINICAL INFORMATION AND PIRADS SCORE

被引：0
|
作者：
Hougen, Helen
Reis, Isildinha M.
Prakash, Nachiketh S.
Blachman-Braun, Ruben
Delgado, Jessica
Ritch, Chad R.
Nahar, Bruno
Gonzalgo, Mark L.
Parekh, Dipen J.
Stoyanova, Radka
Gaston, Sandra M.
Kryvenko, Oleksandr
Mahal, Brandon
Abromowitz, Matthew
Dal Pra, Alan
Pollack, Alan
Punnen, Sanoj
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP55-05
引用
收藏
页码：E764 / E765
页数：2
相关论文
共 50 条
  • [31] Outcomes of men with prostate cancer managed with active surveillance and tested with clinical cell-cycle risk score.
    Ehdaie, Behfar
    Kaul, Sanjeev
    Wojno, Kirk
    Evans, Brent
    Bernhisel, Ryan
    Meek, Stephanie
    D'Anna, Richard
    Ferguson, Jeffrey
    Glaser, Jeffrey
    Morgan, Todd Matthew
    Lieb, Jeremy
    Yan, Robert
    Stone, Steven
    Cohen, Todd
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance
    Sushentsev, Nikita
    Rundo, Leonardo
    Blyuss, Oleg
    Gnanapragasam, Vincent J.
    Sala, Evis
    Barrett, Tristan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [33] CLINICAL PROGRESSION OF PROSTATE CANCER FROM ACTIVE SURVEILLANCE IS PREDICTED BY DECIPHER® GENOMIC CLASSIFIER SCORE ON INDEX BIOPSY INDEPENDENT FROM RISK ASSESSMENT BY MRI CHARACTERISTICS
    Mark, Sultan
    Riley, McGinnis J.
    John, Sheng
    Nimrod, Barashi S.
    Kainen, Utt L.
    Huaping, Jing
    James, Proudfoot A.
    Jason, Hughes D.
    Elai, Davicioni
    Cody, Weimholt R.
    Joseph, Ippolito E.
    Joseph, Ippolito E.
    Eric, Kim H.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 90 - 91
  • [34] MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance
    Nikita Sushentsev
    Leonardo Rundo
    Oleg Blyuss
    Vincent J. Gnanapragasam
    Evis Sala
    Tristan Barrett
    Scientific Reports, 11
  • [35] Low Prostate-specific Antigen and No Gleason Score Upgrade Despite More Extensive Cancer During Active Surveillance Predicts Insignificant Prostate Cancer at Radical Prostatectomy
    Han, Jeong S.
    Toll, Adam D.
    Amin, Ali
    Carter, H. Ballentine
    Landis, Patricia
    Lee, Stephen
    Epstein, Jonathan I.
    UROLOGY, 2012, 80 (04) : 883 - 888
  • [36] IHC4 score plus clinical treatment score predicts locoregional recurrence in early breast cancer
    Lakhanpal, Roopa
    Sestak, Ivana
    Shadbolt, Bruce
    Bennett, Genevieve M.
    Brown, Michael
    Phillips, Tessa
    Zhang, Yanping
    Bullman, Amanda
    Rezo, Angela
    BREAST, 2016, 29 : 147 - 152
  • [37] Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
    Aerts, Jan
    Hendrickx, Sigi
    Berquin, Camille
    Lumen, Nicolaas
    Verbeke, Sofie
    Villeirs, Geert
    Van Praet, Charles
    De Visschere, Pieter
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 56 : 39 - 46
  • [38] VALIDATION OF AN ACTIVE SURVEILLANCE THRESHOLD FOR THE CCP SCORE IN CONSERVATIVELY MANAGED MEN WITH LOCALIZED PROSTATE CANCER
    Cuzick, Jack
    Stone, Steven
    Fisher, Gabrielle
    Yang, Zi Hua
    North, Bernard
    Berney, Daniel
    Beltran, Luis
    Greenberg, David
    Moller, Henrik
    Reid, Julia
    Gutin, Alexander
    Lanchbury, Jerry
    Brawer, Michael
    Scardino, Peter
    JOURNAL OF UROLOGY, 2015, 193 (04): : E4 - E4
  • [39] Clinical and Demographic Characteristics Associated With Prostate Cancer Progression in Patients on Active Surveillance
    Iremashvili, Viacheslav
    Soloway, Mark S.
    Rosenberg, Daniel L.
    Manoharan, Murugesan
    JOURNAL OF UROLOGY, 2012, 187 (05): : 1594 - 1599
  • [40] Preventing clinical progression and need for treatment in patients on active surveillance for prostate cancer
    Goldberg, Hanan
    Klaassen, Zachary
    Chandrasekar, Thenappan
    Fleshner, Neil
    CURRENT OPINION IN UROLOGY, 2018, 28 (01) : 46 - 54
12345